{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T21:46:42Z","timestamp":1783633602227,"version":"3.55.0"},"reference-count":35,"publisher":"American Academy of Pediatrics (AAP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1999,3,1]]},"abstract":"<jats:sec>\n                  <jats:title>Objectives.<\/jats:title>\n                  <jats:p>Primary brain tumors are the most common solid tumors that occur in childhood. With improved management of these tumors, there are more survivors with long-term sequelae of radiation and chemotherapy including growth failure. The aim of this study was to assess growth prospectively in children with nonpituitary-related primary brain tumors.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods.<\/jats:title>\n                  <jats:p>Forty-one children 3.1 to 13.8 years of age diagnosed consecutively between 1989 and 1992 with a primary nonpituitary-related brain tumor were studied.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results.<\/jats:title>\n                  <jats:p>Of 34 prepubertal children, 14 (41%) were diagnosed as having growth hormone (GH) deficiency. All 14 children were treated with cranial irradiation. During the first year from completion of brain tumor therapy, the annual height velocity of those children confirmed subsequently as being GH-deficient was 3.06 \u00b1 1.19 cm compared with 5.29 \u00b1 2.21 cm for those who were not GH-deficient. During the second year, the annual height velocity was 3.29 \u00b1 1.14 cm per year for the GH-deficient group compared with 5.48 \u00b1 1.24 cm per year for the non-GH-deficient group. All children with GH deficiency received cranial irradiation and chemotherapy. Two of 34 children developed precocious puberty. Primary hypothyroidism was diagnosed in 6 of 41 children (12%).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion.<\/jats:title>\n                  <jats:p>We conclude that GH deficiency and primary hypothyroidism are common after cranial irradiation and chemotherapy for nonpituitary-related brain tumors. Linear growth appears to reflect GH status accurately in children with brain tumors. Precise auxologic evaluation is simple and noninvasive and may reflect more accurately GH status than provocative GH testing. These findings reflect the need for prospective growth monitoring of children with nonpituitary-related brain tumors treated with cranial irradiation and chemotherapy. Early diagnosis of GH deficiency facilitates early initiation of GH therapy and optimization of final height.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1542\/peds.103.3.e37","type":"journal-article","created":{"date-parts":[[2004,8,13]],"date-time":"2004-08-13T23:45:45Z","timestamp":1092440745000},"page":"e37-e37","source":"Crossref","is-referenced-by-count":37,"title":["Growth Failure After Treatment of Pediatric Brain Tumors"],"prefix":"10.1542","volume":"103","author":[{"given":"Cheril L.","family":"Clarson","sequence":"first","affiliation":[{"name":"From the Department of Pediatrics and the"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolando F.","family":"Del Maestro","sequence":"additional","affiliation":[{"name":"Brain Research Laboratory, Clinical Research Unit, Division of Neurosurgery, Department of Clinical Neurological Sciences, Children's Hospital of Western Ontario, London, Ontario, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[1999,3,1]]},"reference":[{"key":"2021121000384115900_B1"},{"key":"2021121000384115900_B2"},{"key":"2021121000384115900_B3"},{"key":"2021121000384115900_B4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/canjclin.47.1.5","article-title":"Cancer statistics 1997.","volume":"47","author":"Parker","year":"1997","journal-title":"CA Cancer J Clin"},{"key":"2021121000384115900_B5"},{"key":"2021121000384115900_B6","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0300-595X(86)80011-1","article-title":"Irradiation-induced growth failure.","volume":"15","author":"Shalet","year":"1986","journal-title":"J. Clin Endocrinol Metab"},{"key":"2021121000384115900_B7","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1111\/j.1651-2227.1990.tb11357.x","article-title":"Growth and growth hormone secretion in children following treatment of brain tumors with radiotherapy.","volume":"79","author":"Darendeliler","year":"1990","journal-title":"Acta Paediatr Scand"},{"key":"2021121000384115900_B8","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/0360-3016(90)90392-W","article-title":"The treatment and long-term prognosis of children with intracranial tumors: a study of 610 cases, 1950\u20131981.","volume":"18","author":"Bloom","year":"1990","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2021121000384115900_B9","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/j.1651-2227.1987.tb17273.x","article-title":"A longitudinal study on growth and spontaneous growth hormone (GJH) secretion in children with irradiated brain tumors.","volume":"76","author":"Albertsson-Wikland","year":"1987","journal-title":"Acta Paediatr Scand"},{"key":"2021121000384115900_B10","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1136\/adc.62.5.461","article-title":"Effect of spinal irradiation on growth.","volume":"2","author":"Shalet","year":"1987","journal-title":"Arch Dis Child"},{"key":"2021121000384115900_B11"},{"key":"2021121000384115900_B12","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0022-3476(96)70119-1","article-title":"Final height and hormonal function after bone marrow transplantation in children.","volume":"129","author":"Clement-De Boers","year":"1996","journal-title":"J Pediatr"},{"key":"2021121000384115900_B13"},{"key":"2021121000384115900_B14","first-page":"1282","article-title":"Cranial irradiation and early puberty.","volume":"78","author":"Ogilvy-Stuart","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2021121000384115900_B15"},{"key":"2021121000384115900_B16"},{"key":"2021121000384115900_B17","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1651-2227.1990.tb11509.x","article-title":"Response to growth hormone treatment and final height after cranial or craniospinal irradiation.","volume":"79","author":"Sulmont","year":"1990","journal-title":"Acta Paediatr Scand"},{"key":"2021121000384115900_B18"},{"key":"2021121000384115900_B19","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1002\/1097-0142(19851101)56:9<2189::AID-CNCR2820560909>3.0.CO;2-I","article-title":"Long-term effects of cranial irradiation on endocrine function in children with brain tumors: a prospective study.","volume":"56","author":"Duffner","year":"1985","journal-title":"Cancer"},{"key":"2021121000384115900_B20","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0022-3476(86)80986-6","article-title":"Long-term endocrine sequelae after treatment of medulloblastoma: prospective study of growth and thyroid function.","volume":"108","author":"Oberfield","year":"1986","journal-title":"J Pediatr"},{"key":"2021121000384115900_B21","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0140-6736(75)90006-9","article-title":"Pituitary function after treatment of intracranial tumours in children.","volume":"2","author":"Shalet","year":"1975","journal-title":"Lancet"},{"key":"2021121000384115900_B22","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/mpo.2950250208","article-title":"Chemotherapy-induced growth hormone deficiency in children with cancer.","volume":"25","author":"Roman","year":"1995","journal-title":"Med Pediatr Oncol"},{"key":"2021121000384115900_B23"},{"key":"2021121000384115900_B24","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1159\/000184276","article-title":"Efficacy of growth hormone replacement therapy in children with organic growth hormone deficiency after cranial irradiation.","volume":"43","author":"Vassilopoulou-Sellin","year":"1995","journal-title":"Horm Res"},{"key":"2021121000384115900_B25","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1365-2265.1981.tb02969.x","article-title":"Growth hormone treatment in children with craniopharyngioma: final growth status.","volume":"14","author":"Burns","year":"1981","journal-title":"Clin Endocrinol"},{"key":"2021121000384115900_B26","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0140-6736(87)90355-2","article-title":"Does growth hormone cause relapse of brain tumours?","volume":"1","author":"Clayton","year":"1987","journal-title":"Lancet"},{"key":"2021121000384115900_B27"},{"key":"2021121000384115900_B28"},{"key":"2021121000384115900_B29","first-page":"1177","article-title":"Thyroid tumors following thymus irradiation.","volume":"74","author":"Shore","year":"1985","journal-title":"J Natl Cancer Inst"},{"key":"2021121000384115900_B30","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/mpo.2950170525","article-title":"Second malignant neoplasms following childhood Hodgkin's disease: treatment and splenectomy as risk factors.","volume":"17","author":"Meadows","year":"1989","journal-title":"Med Pediatr Oncol"},{"key":"2021121000384115900_B31","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1093\/ajcn\/55.5.918","article-title":"Body composition in growth hormone-deficient adults.","volume":"55","author":"Binnerts","year":"1992","journal-title":"Am J Clin Nutr"},{"key":"2021121000384115900_B32","first-page":"82","article-title":"Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment.","volume":"82","author":"Attanasio Af, Lamberts SWJ, Matranga AMC, et al, and The Adult Growth Hormone Deficiency Study Group","year":"1997","journal-title":"J Clin Endocrinol"},{"key":"2021121000384115900_B33"},{"key":"2021121000384115900_B34","first-page":"1693","article-title":"Mortality in Canadian children with growth hormone (GH) deficiency receiving GH therapy, 1967\u20131992.","volume":"81","author":"Taback","year":"1996","journal-title":"J Clin Endocrinol"},{"key":"2021121000384115900_B35","doi-asserted-by":"crossref","first-page":"747","DOI":"10.3171\/jns.1997.86.5.0747","article-title":"Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas.","volume":"86","author":"Packer","year":"1997","journal-title":"J Neurosurg"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/103\/3\/e37\/886153\/pe039900e37o.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/103\/3\/e37\/886153\/pe039900e37o.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T07:42:55Z","timestamp":1639122175000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/103\/3\/e37\/62240\/Growth-Failure-After-Treatment-of-Pediatric-Brain"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,3,1]]},"references-count":35,"journal-issue":{"issue":"3","published-online":{"date-parts":[[1999,3,1]]},"published-print":{"date-parts":[[1999,3,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.103.3.e37","relation":{},"ISSN":["1098-4275","0031-4005"],"issn-type":[{"value":"1098-4275","type":"electronic"},{"value":"0031-4005","type":"print"}],"subject":[],"published":{"date-parts":[[1999,3,1]]}}}